Staphylococcus Infection: Relapsing Atopic Dermatitis and Microbial Restoration
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hulme, John P. | - |
dc.date.accessioned | 2023-03-09T01:40:07Z | - |
dc.date.available | 2023-03-09T01:40:07Z | - |
dc.date.created | 2023-01-24 | - |
dc.date.issued | 2023-02 | - |
dc.identifier.issn | 2079-6382 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/87023 | - |
dc.description.abstract | Atopic Dermatitis (AD) skin is susceptible to Staphylococcus aureus (SA) infection, potentially exposing it to a plethora of toxins and virulent determinants, including Panton-Valentine leukocidin (PVL) (α-hemolysin (Hla) and phenol-soluble modulins (PSMs)), and superantigens. Depending on the degree of infection (superficial or invasive), clinical treatments may encompass permanganate (aq) and bleach solutions coupled with intravenous/oral antibiotics such as amoxicillin, vancomycin, doxycycline, clindamycin, daptomycin, telavancin, linezolid, or tigecycline. However, when the skin is significantly traumatized (sheathing of epidermal sections), an SA infection can rapidly ensue, impairing the immune system, and inducing local and systemic AD presentations in susceptible areas. Furthermore, when AD presents systemically, desensitization can be long (years) and intertwined with periods of relapse. In such circumstances, the identification of triggers (stress or infection) and severity of the flare need careful monitoring (preferably in real-time) so that tailored treatments targeting the underlying pathological mechanisms (SA toxins, elevated immunoglobulins, impaired healing) can be modified, permitting rapid resolution of symptoms. © 2023 by the author. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | Antibiotics | - |
dc.title | Staphylococcus Infection: Relapsing Atopic Dermatitis and Microbial Restoration | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000937902500001 | - |
dc.identifier.doi | 10.3390/antibiotics12020222 | - |
dc.identifier.bibliographicCitation | Antibiotics, v.12, no.2, pp.1 - 18 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85148890083 | - |
dc.citation.endPage | 18 | - |
dc.citation.startPage | 1 | - |
dc.citation.title | Antibiotics | - |
dc.citation.volume | 12 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Hulme, John P. | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | atopic | - |
dc.subject.keywordAuthor | dermatitis | - |
dc.subject.keywordAuthor | infection | - |
dc.subject.keywordAuthor | relapsing | - |
dc.subject.keywordAuthor | restoration | - |
dc.subject.keywordAuthor | Staphylococcus aureus | - |
dc.relation.journalResearchArea | Infectious Diseases | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Infectious Diseases | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.